{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-036178","form_type":"8-K","ticker":"DH","cik":"0001861795","company_name":"Definitive Healthcare Corp.","filed_at":"2023-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.863506+00:00","generated_at":"2026-06-12T19:10:38.179253+00:00","sec_items":["2.02","2.05","4.02","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Definitive Healthcare restates prior financials due to sales tax error; Q2 rev $61M, cuts 4% workforce","bullets":["Restates 2020-2022 and Q1 2023 financials over sales tax; expects G&A expense increase of $6.8M-$10.2M.","Preliminary Q2 revenue $61M, net loss $11.4-11.8M, adj. EBITDA $17.2M; reaffirms FY revenue $249-255M and adj. EBITDA $67-71M.","Cuts 42 jobs (~4% workforce); expects pre-tax restructuring charges of $1.8M-$2.0M in Q3 2023.","Material weakness in internal control over financial reporting identified; Q2 2023 earnings call moved to Aug 14."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-036178","json":"https://secwatch.observer/filing/0000950170-23-036178.json","markdown":"https://secwatch.observer/filing/0000950170-23-036178.md","text":"https://secwatch.observer/filing/0000950170-23-036178.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861795/000095017023036178/0000950170-23-036178-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861795/000095017023036178/dh-20230727.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T19:10:38.179253+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"add74c3aaa4aca1ad041cf736565f4223cb2953b","claim":"Definitive Healthcare Corp. reported the quarter ended June 30, 2023 results: revenue $61.0 million, net income in the range of $11.4 million to $11.8 million or $(0.08) per share, EPS $(0.08) per share. Guidance reaffirmed.","evidence_excerpt":"Second Quarter 2023 Financial Highlights: • Revenue is expected to be $61.0 million • Net loss is expected to be in the range of $11.4 million to $11.8 million or $(0.08) per share • Adjusted Net Income is expected to be in the range of $12.3 million to $12.4 million or $0.08 per diluted share • Adjusted EBITDA is expected to be $17.2 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000095017023036178/0000950170-23-036178-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Revenue","value":"$61.0 million"},{"label":"Net income","value":"in the range of $11.4 million to $11.8 million or $(0.08) per share"},{"label":"EPS","value":"$(0.08) per share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"55f94408fa4936fc19ed01c03db4476a7c4966d8","claim":"Definitive Healthcare Corp. announced a restructuring with charges of approximately $1.8 million to $2.0 million (42 people, or approximately 4 percent of its total workforce).","evidence_excerpt":"On July 27, 2023, the Company committed to a restructuring plan (the “Plan”) intended to reduce operating costs, improve operating margins, and continue advancing the Company’s ongoing commitment to profitable growth. The Plan provides for a reduction of the Company’s current workforce by 42 people, or approximately 4 percent of its total workforce. The Company estimates that in the third quarter of 2023 it will incur pre-tax cash restructuring and related charges to its GAAP financial results of approximately $1.8 million to $2.0 million, consisting primarily of severance payments, employee benefits, and related cash expenses, as well as a non-cash charge related to the vesting of share-based awards for employees who are terminated.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000095017023036178/0000950170-23-036178-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $1.8 million to $2.0 million"},{"label":"Headcount","value":"42 people, or approximately 4 percent of its total workforce"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}